- Advertisement -
A viral replicon system suited to the stable replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), without cytopathic effects, has been reported recently in a study appearing on the bioRxiv* preprint server.
Study: Stable Cell…

